Renal Cancer - Results from #4400

Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection July 9, 2018

Retrospective analysis on the efficacy of sunitinib/sorafenib in combination with dendritic cells-cytokine-induced killer in metastasis renal cell carcinoma after radical nephrectomy July 9, 2018

A Complex Cardiac Mass Originating from Interatrial Septum in a Patient with History of Kidney Cancer: A Case Report and Literature Review July 6, 2018

Oridonin enhances the cytotoxicity of 5-FU in renal carcinoma cells by inducting necroptotic death July 4, 2018

Genetic Polymorphism on the Pharmacokinetics and Pharmacodynamics of Platelet-derived Growth Factor Receptor (PDGFR) Kinase Inhibitors July 4, 2018

Cabozantinib-induced serum creatine kinase elevation and musculoskeletal complaints July 3, 2018

Safety and Efficacy of Nivolumab for Metastatic Renal Cell Carcinoma: Real-World Results From an Expanded Access Program July 2, 2018

Evaluation and prognostic significance of manganese superoxide dismutase in clear cell renal cell carcinoma June 29, 2018

Age alone is not a contraindication to kidney donation: Outcomes of donor nephrectomy in the elderly June 29, 2018

Survival outcomes for advanced kidney cancer patients in the era of targeted therapies June 28, 2018

Potential impact of PD-L1 (SP-142) immunohistochemical heterogeneity in clear cell renal cell carcinoma immunotherapy June 28, 2018

The classification of pediatric and young adult renal cell carcinomas registered on the Children's Oncology Group (COG) protocol AREN03B2 after focused genetic testing June 28, 2018

Periprocedural outcome after laparoscopic partial nephrectomy versus radiofrequency ablation for T1 renal tumors: a modified R.E.N.A.L nephrometry score adjusted comparison June 27, 2018

Prevalence and outcomes of incidental imaging findings: umbrella review June 27, 2018

Surgical approach does not impact margin status following partial nephrectomy for large renal masses June 27, 2018

Risk of hematologic toxicities with programmed cell death-1 inhibitors in cancer patients: a meta-analysis of current studies June 27, 2018

Time trends in the prevalence of cancer and non-cancer diseases among older U.S. adults: Medicare-based analysis June 26, 2018

Quantification of sarcomatoid differentiation in renal cell carcinoma on magnetic resonance imaging June 26, 2018

Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study June 26, 2018

Predictors, utilization patterns, and overall survival of patients undergoing metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy June 25, 2018

Page 221 of 457